(Q21144326)

English

Safety and immunogenicity of a malaria vaccine, Plasmodium falciparum AMA-1/MSP-1 chimeric protein formulated in montanide ISA 720 in healthy adults

scientific article

In more languages

Statements

scholarly article

0 references

Safety and immunogenicity of a malaria vaccine, Plasmodium falciparum AMA-1/MSP-1 chimeric protein formulated in montanide ISA 720 in healthy adults (English)

0 references

0 references

Plasmodium falciparum

0 references

0 references

malaria vaccine

1 reference

based on heuristic

inferred from title

object named as

Yang Cao

13

author given names

Yang

author last names

Cao

1 reference

16 August 2022

author name string

Jinhong Hu

1

author given names

Jinhong

author last names

Hu

1 reference

16 August 2022

Zhihui Chen

2

author given names

Zhihui

author last names

Chen

1 reference

16 August 2022

Jun Gu

3

author given names

Jun

author last names

Gu

1 reference

16 August 2022

Mobin Wan

4

author given names

Mobin

author last names

Wan

1 reference

16 August 2022

Qian Shen

5

author given names

Qian

author last names

Shen

1 reference

16 August 2022

Marie-Paule Kieny

6

author given names

Marie-Paule

author last names

Kieny

1 reference

16 August 2022

Jia He

7

author given names

Jia

author last names

He

1 reference

16 August 2022

Zhen Li

8

author given names

Zhen

author last names

Li

1 reference

16 August 2022

Qingfeng Zhang

9

author given names

Qingfeng

author last names

Zhang

1 reference

16 August 2022

Zarifah Hussain Reed

10

author given names

Zarifah Hussain

author last names

Reed

1 reference

16 August 2022

Yongmei Zhu

11

author given names

Yongmei

author last names

Zhu

1 reference

16 August 2022

Wenjie Li

12

author given names

Wenjie

author last names

Li

1 reference

16 August 2022

Li Qu

14

author given names

Li

author last names

Qu

1 reference

16 August 2022

Zhifang Cao

15

author given names

Zhifang

author last names

Cao

1 reference

16 August 2022

Qiang Wang

16

author given names

Qiang

author last names

Wang

1 reference

16 August 2022

Haitao Liu

17

author given names

Haitao

author last names

Liu

1 reference

16 August 2022

Xuegong Pan

18

author given names

Xuegong

author last names

Pan

1 reference

16 August 2022

Xiudong Huang

19

author given names

Xiudong

author last names

Huang

1 reference

16 August 2022

Dongmei Zhang

20

author given names

Dongmei

author last names

Zhang

1 reference

16 August 2022

Xiangyang Xue

21

author given names

Xiangyang

author last names

Xue

1 reference

16 August 2022

Weiqing Pan

22

author given names

Weiqing

author last names

Pan

1 reference

16 August 2022

language of work or name

0 references

publication date

2008

0 references

0 references

3

0 references

4

0 references

e1952

0 references

copyright license

Creative Commons Attribution 4.0 International

9 April 2008

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

The global distribution of clinical episodes of Plasmodium falciparum malaria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276862

19 March 2017

Structure of domain III of the blood-stage malaria vaccine candidate, Plasmodium falciparum apical membrane antigen 1 (AMA1)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276862

19 March 2017

Drug discovery for malaria: a very challenging and timely endeavor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276862

12 September 2017

Induration at or near injection site: case definition and guidelines for collection, analysis, and presentation of immunization safety data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276862

12 September 2017

Swelling at or near injection site: case definition and guidelines for collection, analysis and presentation of immunization safety data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276862

12 September 2017

Evaluation of three Pichia pastoris-expressed Plasmodium falciparum merozoite proteins as a combination vaccine against infection with blood-stage parasites

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276862

12 September 2017

Phase 1 clinical trial of apical membrane antigen 1: an asexual blood-stage vaccine for Plasmodium falciparum malaria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276862

12 September 2017

Domain III of Plasmodium falciparum apical membrane antigen 1 binds to the erythrocyte membrane protein Kx.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276862

12 September 2017

Merozoite surface antigen-I of plasmodium

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276862

12 September 2017

Protection against Plasmodium chabaudi malaria induced by immunization with apical membrane antigen 1 and merozoite surface protein 1 in the absence of gamma interferon or interleukin-4.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276862

12 September 2017

Nodule at injection site as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276862

12 September 2017

Maternally transmitted antibodies to pregnancy-associated variant antigens on the surface of erythrocytes infected with Plasmodium falciparum: relation to child susceptibility to malaria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276862

12 September 2017

Antibodies against merozoite surface protein (MSP)-1(19) are a major component of the invasion-inhibitory response in individuals immune to malaria.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276862

12 September 2017

Antibodies and Plasmodium falciparum merozoites

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276862

12 September 2017

Malaria vaccines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276862

12 September 2017

Estimating mortality, morbidity and disability due to malaria among Africa's non-pregnant population.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276862

12 September 2017

Human phase I vaccine trials of 3 recombinant asexual stage malaria antigens with Montanide ISA720 adjuvant

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276862

12 September 2017

Merozoite surface coat precursor protein completely protects Aotus monkeys against Plasmodium falciparum malaria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276862

12 September 2017

A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276862

12 September 2017

Construction and evaluation of a multistage combination vaccine against malaria.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276862

30 May 2018

Vaccination trials in rhesus monkeys with a minor, invariant, Plasmodium knowlesi 66 kD merozoite antigen.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276862

30 May 2018

Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2276862

30 May 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0001952

21 January 2018

Gamma-globulin and acquired immunity to human malaria.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0001952

21 January 2018

Plasmodium falciparum: two antigens of similar size are located in different compartments of the rhoptry

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0001952

21 January 2018

Pathways and strategies for developing a malaria blood-stage vaccine

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0001952

21 January 2018

Apical membrane antigen 1 plays a central role in erythrocyte invasion by Plasmodium species.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0001952

21 January 2018

Immunization against blood-stage rodent malaria using purified parasite antigens.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0001952

21 January 2018

Human antibodies to the 19kDa C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 inhibit parasite growth in vitro.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0001952

21 January 2018

Crystal structure of the malaria vaccine candidate apical membrane antigen 1.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0001952

21 January 2018

Fusion of two malaria vaccine candidate antigens enhances product yield, immunogenicity, and antibody-mediated inhibition of parasite growth in vitro

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0001952

21 January 2018

Phase I safety and immunogenicity trial of FMP1/AS02A, a Plasmodium falciparum MSP-1 asexual blood stage vaccine

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0001952

21 January 2018

In vivo veritas: lessons from immunoglobulin-transfer experiments in malaria patients

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0001952

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1371/JOURNAL.PONE.0001952

0 references

2008PLoSO...3.1952H

0 references

0 references

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q21144326&oldid=1871644559"